This review assesses digital rectal examination's impact on prostate cancer detection in the context of MRI advancements, suggesting improved diagnostic pathways.
Key Points
To evaluate the role of digital rectal examination in diagnosing prostate cancer alongside modern MRI techniques.
Retrospective review of patients referred for suspected prostate cancer based on abnormal DRE.
Assessment of concurrent PSA levels and cancer detection rates.
Comparison of detection rates in patients with abnormal DRE and normal PSA versus elevated PSA.
Overall detection rate of clinically significant cancer was 14%.
Detection rate for cancer was 3% in patients with abnormal DRE but normal PSA.
Detection rate was 29% for those with both abnormal DRE and elevated PSA.